FMC stock falls 0.49 percent pre-market before November 3 results
Published on 10/28/2026 at 07:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSReporting date and business model
- Fresenius Medical Care has scheduled third-quarter reporting for November 3, 2026.
- The company provides kidney care services and related products for people with kidney disease.
- FMC stock trades pre-market at EUR 40.37 at 7:52 a.m. CET at Lang & Schwarz on October 28, 2026, 0.49 percent below the Xetra close of October 27, 2026.
Fresenius Medical Care's investor calendar lists November 3, 2026, for its third-quarter 2026 reporting, according to the company's investor-relations page. FMC stock trades pre-market at EUR 40.37 at 7:52 a.m. CET at Lang & Schwarz on October 28, 2026, 0.49 percent below the Xetra close of October 27, 2026 (EUR 40.57).
The next reporting date
The company calendar identifies November 3, 2026, as the date for publication of third-quarter business results and a conference call. The date is listed on Fresenius Medical Care's investor-relations page.
Ahead of the Xetra open
The pre-market indication is EUR 0.20 lower than the reference close. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of FMC stock.
Business and today's agenda
Fresenius Medical Care provides kidney care services and related products for people with kidney disease, as described on its investor-relations page. The next listed reporting event is November 3, 2026. Market context: Market report DAX.
